A negative urine PCR is sufficient—you do not need to add on a vaginal PCR
For a patient with vaginal discharge who has a negative urine NAAT for NG/CT, you do not need to order an additional vaginal specimen test. The urine test is adequate for ruling out these infections in this clinical scenario.
Rationale Based on Guidelines
The CDC guidelines explicitly state that NAATs for C. trachomatis and N. gonorrhoeae "can be performed on either cervical or urine samples" when evaluating cervicitis and vaginal discharge 1. This equivalence is reinforced across multiple guideline iterations, which consistently note that NAATs are FDA-cleared for use with multiple specimen types including urine, endocervical swabs, and vaginal swabs 1.
The 2014 CDC laboratory recommendations confirm that NAATs cleared by the FDA for detection of CT and NG are recommended as screening or diagnostic tests and that these tests perform well across different specimen types 2. The guidelines make no distinction requiring vaginal specimens over urine for symptomatic women with discharge.
Supporting Research Evidence
Recent systematic reviews demonstrate that urine NAATs have comparable sensitivity and specificity to vaginal and cervical specimens:
- A 2005 systematic review found pooled sensitivities for CT in women using urine specimens ranged from 79.9% to 92.5% depending on the assay platform, with specificities exceeding 97% 3
- A 2019 systematic review comparing vaginal specimens to other sites found that vaginal specimens achieved similar performance to cervical and urine specimens for both CT (vaginal 65-100%, urine 57-100%) and NG (vaginal 64-100%, urine 67-94%) 4
Important Caveats
While urine testing is sufficient for your clinical scenario, be aware of these nuances:
- Vaginal specimens may have slightly higher sensitivity than urine for CT in some studies, with one recent study showing vaginal swabs missed 2 CT infections that midstream urine detected, yielding 92.9% sensitivity for midstream urine versus higher sensitivity for vaginal swabs 5
- However, this difference is not clinically significant enough to warrant routine dual testing when a negative urine NAAT has already been obtained
- The performance differences between specimen types are assay-dependent, with transcription-mediated amplification (TMA) and strand displacement amplification (SDA) generally outperforming PCR, particularly for NG detection 3, 6
Clinical Bottom Line
Your negative urine PCR effectively rules out NG and CT as causes of this patient's vaginal discharge. Focus your diagnostic workup on other causes of vaginal discharge such as bacterial vaginosis, trichomoniasis (which may require separate testing as it's not always included in standard NG/CT panels), or candidiasis 1. Adding a vaginal NAAT would be redundant, not cost-effective, and unlikely to change management given the high negative predictive value of urine NAATs.